CHMP1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.111000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.789400E-01
Normal-vs-Stage2
7.604000E-01
Normal-vs-Stage3
5.694800E-01
Normal-vs-Stage4
8.387600E-01
Stage1-vs-Stage2
4.545400E-01
Stage1-vs-Stage3
7.080600E-01
Stage1-vs-Stage4
6.507600E-01
Stage2-vs-Stage3
3.136600E-01
Stage2-vs-Stage4
9.878400E-01
Stage3-vs-Stage4
5.505400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.311000E-01
Normal-vs-AfricanAmerican
5.983000E-01
Normal-vs-Asian
7.737800E-01
Caucasian-vs-AfricanAmerican
5.165800E-01
Caucasian-vs-Asian
8.796800E-01
AfricanAmerican-vs-Asian
6.781000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.535800E-01
Normal-vs-Female
7.481200E-01
Male-vs-Female
7.509600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.171600E-01
Normal-vs-Age(41-60Yrs)
3.309800E-01
Normal-vs-Age(61-80Yrs)
8.077200E-01
Normal-vs-Age(81-100Yrs)
9.733400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.692600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.587600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.416000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.22380000000078E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.998000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.955200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.902400E-01
Normal-vs-Daily Drinker
9.667400E-01
Normal-vs-Weekly Drinker
6.591600E-01
Normal-vs-Occasional Drinker
6.152600E-01
Normal-vs-Social Drinker
7.168200E-01
Non Drinker-vs-Daily Drinker
9.073200E-01
Non Drinker-vs-Weekly Drinker
5.175400E-01
Non Drinker-vs-Occasional Drinker
2.412200E-01
Non Drinker-vs-Social Drinker
5.263800E-01
Daily Drinker-vs-Weekly Drinker
4.923600E-01
Daily Drinker-vs-Occasional Drinker
3.395000E-01
Daily Drinker-vs-Social Drinker
6.383800E-01
Weekly Drinker-vs-Occasional Drinker
1.370600E-01
Weekly Drinker-vs-Social Drinker
2.016800E-01
Occasional Drinker-vs-Social Drinker
5.999400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.605440E-01
Normal-vs-Grade 2
9.422100E-02
Normal-vs-Grade 3
4.042200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.372000E-01
Grade 1-vs-Grade 3
1.216580E-01
Grade 1-vs-Grade 4
1.605440E-01
Grade 2-vs-Grade 3
6.702400E-01
Grade 2-vs-Grade 4
9.422100E-02
Grade 3-vs-Grade 4
4.042200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.498800E-01
Normal-vs-NonDiabetic
7.774800E-01
Diabetic-vs-NonDiabetic
2.940600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.227400E-01
Normal-vs-NoPancreatitis
8.587600E-01
Pancreatitis-vs-NoPancreatitis
6.893600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.816400E-01
Normal-vs-N1
7.715000E-01
N0-vs-N1
5.488000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.763600E-01
Normal-vs-TP53-NonMutant
2.739200E-01
TP53-Mutant-vs-TP53-NonMutant
1.819690E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
